Skip to main content

Thermo Fisher Scientific's Applied Biosystems QuantStudio 3 and QuantStudio 5

Thermo Fisher Scientific has launched the Applied Biosystems QuantStudio 3 and QuantStudio 5, real-time PCR systems that fully integrate with cloud computing technology. The systems are designed for low- to mid-throughput laboratories conducting real-time PCR experiments, and are the first to connect to the Thermo Fisher Cloud computing platform, allowing geographically dispersed researchers to collaborate online in real time and access their data wherever and whenever necessary. Laboratories can also share experimental conditions and results with their partners, provide a uniform experience for every user, and help minimize training and errors. The new instruments integrate with existing analysis workflows including next-generation sequencing, capillary electrophoresis, and qPCR applications. Interactive touch-screen controls allow scientists to directly manage experiments with intuitive commands. As with the existing QuantStudio 6, 7, and 12K Flex instruments, the 3 and 5 include the Thermo Scientific OptiFlex white LED optical system and VeriFlex thermal technology.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.